Doseology Sciences Inc. (DOSEF)
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercialization of medicinal mushroom products, offered in various forms such as tinctures and powders. Customers can acquire these items directly through its official e-commerce platform, doseology.com. Founded in 2019, Doseology Sciences Inc. is headquartered in Kelowna, Canada.
Sector: Medical - Pharmaceuticals
Industry: Medical - Pharmaceuticals
Doseology Sciences Inc.
- 0.0%
- 70
- 1.09
Float 1.94M · FMP free float
The cost to borrow DOSEF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- 59
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 70 sh |
| Oct 15, 2026 | 70 sh |
| Sep 30, 2026 | 70 sh |
| Sep 15, 2026 | 70 sh |
| Aug 31, 2026 | 70 sh |
Latest fails to deliver
| Date | Shares failed |
|---|---|
| Apr 23, 2026 | 59 sh |
| Apr 22, 2026 | 700 sh |
| Apr 21, 2026 | 800 sh |
| Apr 15, 2026 | 304 sh |
A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Too few published sessions to show a reading in context.
FINRA's weekly alternative trading system (dark pool) volume for DOSEF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 70 DOSEF shares were sold short (<0.01% of a 1.94M-share float, 1.09 days to cover).